NCT02496676: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02496676 |
|---|---|
| Title | A Double-blind, Placebo-controlled, Crossover Study of Magnesium Supplementation in Patients With XMEN Syndrome |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 17, 2016 |
| Completion date | April 23, 2020 |
| Required reporting date | April 23, 2023, midnight |
| Actual reporting date | Oct. 27, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |